Serotonin syndrome

Buckley, Nicholas A.; Dawson, Andrew H.; Isbister, Geoffrey K.
March 2014
BMJ: British Medical Journal;3/1/2014, Vol. 348 Issue 7947, p33
Academic Journal
The article discusses the serotonin syndrome which is a fatal and avoidable adverse drug reaction caused by serotonergic drugs. Topics discussed include the epidemiology of serotonin syndrome also known as serotonin toxicity, severe or life threatening effects from stimulation of serotonin 5-hydroxytryptamine, 5-HT receptors, the classic triad of clinical features of serotonin toxicity and clinical diagnosis of serotonin syndrome.


Related Articles

  • Bupropion/citalopram/tramadol.  // Reactions Weekly;2/8/2014, Issue 1487, p11 

    The article presents a case study of a 53-year-old man diagnosed with serotonin syndrome developed while receiving bupropion/citalopram/tramadol.

  • Lorcaserin.  // AHFS Consumer Medication Information;Jan2020, p1 

    Lorcaserin is used to help adults who are obese or who are overweight and have weight-related medical problems to lose weight and keep from gaining back that weight. Lorcaserin must be used along with a reduced calorie diet and an exercise plan. Lorcaserin is in a class of medications called...

  • Adverse Drug Effects and Their Clinical Management: A Personal View. Edwards, I. // Drug Safety;Jun2014, Vol. 37 Issue 6, p383 

    This paper describes the personal views of the author about diagnosis and management of an adverse drug effect. It proposes that diagnosis is complicated and is also supported by carefully observed management of changes in drug therapy. Drug-related adverse effects may be due to the drug itself,...

  • Escitalopram/metoclopramide interaction.  // Reactions Weekly;10/10/2009, Issue 1273, p15 

    The article describes the case of a patient who developed serotonin syndrome and oculogyric crisis after receiving escitalopram/metoclopramide for depression. Symptoms manifested include migraine, tachycardia, diaphoresis, muscle tension, xerostomia, increased blood pressure, and psychomotor...

  • Fluoxetine/methylthioninium chloride interaction.  // Reactions Weekly;May2015, Vol. 1553 Issue 1, p152 

    The article presents a case study of a 25-year-old man who developed serotonin syndrome after concomitant therapy with fluoxetine and methylthioninium chloride.

  • Citalopram/nortriptyline interaction.  // Reactions Weekly;May2015, Vol. 1550 Issue 1, p61 

    The article presents a case study of a 68-year-old man who developed serotonin syndrome while receiving citalopram and nortriptyline as treatment for anxiety, depression and Pancoast tumour.

  • Citalopram overdose.  // Reactions Weekly;Aug2015, Vol. 1563 Issue 1, p61 

    The article presents a case study of a 39-year-old woman who developed serotonin syndrome and cardiorespiratory arrest after citalopram overdose

  • Amiodarone-induced Thyrotoxicosis in Children and Adolescents is a Possible Outcome in Patients with Low Iodine Intake. Hacıhamdiğlu, Bülent; Berberoğlu, Merih; Şıklart, Zeynep; Erdeve, Şenay Savaş; Öçal, Gönül; Tutar, Ercan; Atalay, Semra // Journal of Pediatric Endocrinology & Metabolism;Apr2010, Vol. 23 Issue 4, p363 

    The article discusses research on the differential diagnosis and therapies of amiodarone-induced thyrotoxicosis (AIT) in children and adolescent. The study stated that identifying the types of AIT could help determine the appropriate medical treatment. It was found that AIT is common in...

  • Stop Chemo Nausea. Dellapena, Deb; Harrar, Sarí // Prevention;Sep2003, Vol. 55 Issue 9, p168 

    Reports on the U.S. Food and Drug Administration's approval of Emend aprepitant, a pill used to prevent both immediate and delayed stomach upsets from emetogenic chemotherapy. Mechanism of action of emend aprepitant; Side effects and contraindications.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics